Literature DB >> 947029

Pharmacokinetic approach to the clinical use of lidocaine intravenously.

D J Greenblatt, V Bolognini, J Koch-Weser, J S Harmatz.   

Abstract

The time course of lidocaine plasma concentrations following various modes of administration were predicted by computer. Initiating therapy with a single intravenous bolus dose was unsatisfactory; plasma levels during the first hour were potentially toxic after a 200-mg bolus and subtherapeutic after a 50- to 100-mg bolus. After two bolus doses of 100 mg, separated by 20 to 30 minutes, or a rapid loading infusion over 15 to 60 minutes, therapeutic concentrations were achieved and maintained. Pharmacokinetic principles can be of value in devising rational approaches to lidocaine dosage.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 947029

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Lignocaine: a new technique for intravenous administration.

Authors:  R A Levy; Y Charuzi; W J Mandel
Journal:  Br Heart J       Date:  1977-09

Review 2.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

3.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

4.  Evaluation of infusion regimens for thiopentone as a primary anaesthetic agent.

Authors:  D P Crankshaw; N E Edwards; G L Blackman; M D Boyd; H N Chan; D J Morgan
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

6.  Observations on intravenous administration of lignocaine in patients with myocardial infarction.

Authors:  N P Campbell; J G Kelly; A A Adgey; D G McDevitt; J F Pantridge
Journal:  Br Heart J       Date:  1978-12

7.  Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest.

Authors:  Mohamud R Daya; Brian G Leroux; Paul Dorian; Thomas D Rea; Craig D Newgard; Laurie J Morrison; Joshua R Lupton; James J Menegazzi; Joseph P Ornato; George Sopko; Jim Christenson; Ahamed Idris; Purav Mody; Gary M Vilke; Caroline Herdeman; David Barbic; Peter J Kudenchuk
Journal:  Circulation       Date:  2020-01-16       Impact factor: 29.690

Review 8.  Arrhythmia prophylaxis after acute myocardial infarction: a decade of controversy.

Authors:  D C Harrison
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

9.  Evaluation of Lidocaine and Metabolite Pharmacokinetics in Hyaluronic Acid Injection.

Authors:  Ju Hee Kim; Dong Wook Kang; Go-Wun Choi; Sang Bok Lee; Seongjin Lee; Hea-Young Cho
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.